Abstract
OBJECTIVES: To record the current use of tranexamic acid during traumatic haemorrhage and elective arthroplasty of the hip and knee. DESIGN: A questionnaire-based postal survey. SETTING: The questionnaire was sent to the 'anaesthetic lead' at all acute trusts in England, excluding centres for children, women's health, cancer and cardiac care. PARTICIPANTS: Ninety-nine (66%) centres replied to the questionnaire. MAIN OUTCOME MEASURES: Is tranexamic acid used as part of routine standardized treatment for traumatic haemorrhage and for elective hip and knee arthroplasty, and if so what dosage regime was administered? RESULTS: Few trusts (31%) use tranexamic acid during traumatic haemorrhage, with various dosages used. Its use in hip and knee arthroplasty was also low (38%) with a diverse range of doses prescribed. CONCLUSIONS: Despite many trials showing its efficacy and low risk of side effect, it is clear that its use is not part of standard practice in most centres. Further studies could clarify these concerns and provide a definitive dosing schedule improving patient care and saving lives.